Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Aug 2026 for OptimizeRx Corp.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brendan W. Merrell: trading record in brief
Brendan W. Merrell discloses dealings in OptimizeRx Corp to SEC (Form 4). We count 6 filings; the first trade dates from 21 August 2025 and the latest from 21 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 24 August 2026 with a share grant in OptimizeRx Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brendan W. Merrell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
57,600 shares0Common StockSEC:0001628280-26-058670:0
1,020 shares@ US$7.710.0069% mcap36.2% of flowCommon StockSEC:0001628280-26-058589:0
289 shares@ US$13.5128.1% of flowCommon StockSEC:0001628280-25-058410:0
712 shares@ US$14.03100.0% of flowCommon StockSEC:0001628280-25-057201:0
10,417 shares0Common StockSEC:0001628280-25-050825:0
5 of 5 declarations
